Organigram Global (OGI) Non-Current Deferred Tax Liability (2018 - 2023)

Organigram Global (OGI) posted quarterly Non-Current Deferred Tax Liability of $10.3 million for Q3 2023, up 265.57% on a QoQ basis from $2.8 million in Q3 2022.

Organigram Global (OGI) Non-Current Deferred Tax Liability (2018 - 2023) Analysis & Trends

Organigram Global (OGI) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $10.3 million the latest figure, recorded in Q3 2023.

  • Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $10.3 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $10.3 million (changed N/A YoY) and the FY2023 annual result came in at $10.2 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability rose to $10.3 million in Q3 2023 per OGI's latest filing, from $2.8 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for OGI reached as high as $16.8 million in Q2 2019 and fell as low as $2.8 million in Q3 2022.
  • A 4-year average of $11.2 million and a median of $10.3 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • The largest YoY upside for Non-Current Deferred Tax Liability was 14.79% in 2019 against a maximum downside of 14.79% in 2019.
  • Year by year, Non-Current Deferred Tax Liability stood at $16.0 million in 2019, then sank by 37.73% to $10.0 million in 2020, then tumbled by 71.84% to $2.8 million in 2022, then soared by 265.57% to $10.3 million in 2023.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $10.3 million, $2.8 million, and $10.0 million for Q3 2023, Q3 2022, and Q1 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 10.27 Mn
Sep 30, 2023 10.27 Mn
Aug 31, 2022 2.81 Mn
Aug 31, 2022 2.81 Mn
Feb 29, 2020 9.98 Mn
Feb 29, 2020 9.98 Mn
Aug 31, 2019 16.02 Mn
Aug 31, 2019 16.02 Mn
May 31, 2019 16.76 Mn
May 31, 2019 16.76 Mn
Aug 31, 2018 13.96 Mn
Aug 31, 2018 13.96 Mn